Sirt3 has demonstrated neuroprotective effects in MPTP-induced PD models by deacetylating SOD2 and ATP synthase β [19], and in rotenone-induced PD models by deacetylating SDHA, thereby restoring ATP generation and mitochondrial energy metabolism [62]. This evidence concerns the gene SOD2 and Parkinson disease.